In this episode of WCG Talks Trials, join Silvio Galea, chief data and analytics officer, WCG, and Melissa Hutchens, vice president of research and benchmarking, WCG, as they discuss the transformative role of AI in clinical trials. Discover how generative AI and other AI technologies are enhancing the quality of clinical trials, reducing cycle times, and cutting costs. The episode covers the benefits, barriers, and concerns associated with AI, and explores its applications in drug discovery, participant recruitment, trial design, and more. Tune in to learn about the latest advancements in AI and how they are shaping the future of clinical trials.  

Guests: 

  • Silvio Galea, chief data and analytics officer, WCG 
  • Melissa Hutchens, vice president of research and benchmarking, WCG 

Podden och tillhörande omslagsbild på den här sidan tillhör WCG. Innehållet i podden är skapat av WCG och inte av, eller tillsammans med, Poddtoppen.

WCG Talks Trials

AI in Clinical Trials: Unlocking the Potential

00:00